Related Experiment Video

Updated: Jun 1, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Notch signaling as a therapeutic target for breast cancer treatment?

Jianxun Han1, Michael J Hendzel, Joan Allalunis-Turner

  • 1Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

Breast Cancer Research : BCR
|June 16, 2011
PubMed

Insights

Inhibiting Notch signaling shows promise for breast cancer treatment, but further research is needed to address uncertainties and optimize therapeutic strategies, especially RBPjκ-independent pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Aberrant Notch signaling is implicated in mammary gland carcinoma development.
  • High Notch receptor and ligand expression correlates with poor breast cancer prognosis.

Purpose of the Study:

  • To critically evaluate the evidence for and against Notch signaling inhibition in breast cancer treatment.
  • To identify uncertainties and guide future experimental research.
  • To explore the role of RBPjκ-independent Notch pathways in tumorigenesis.

Main Methods:

  • Literature review and critical analysis of existing studies.
  • Evaluation of preclinical and clinical data on Notch signaling in breast cancer.
  • Assessment of the contribution of RBPjκ-independent pathways.

Main Results:

  • Evidence suggests Notch inhibition may be beneficial, but significant uncertainties remain.
  • Notch4 activity can drive mammary gland carcinoma independently of RBPjκ.
  • Understanding RBPjκ-independent pathways is crucial for targeted therapies.

Conclusions:

  • Notch inhibition, particularly in combination therapies, is a promising strategy for breast cancer management.
  • Further experimental validation is required to overcome current limitations.
  • Elucidating RBPjκ-independent Notch signaling is key to developing effective treatment strategies.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...